Related Experiment Video
Updated: Feb 7, 2026

Pancreatic Tissue-Derived Extracellular Matrix Bioink for Printing 3D Cell-Laden Pancreatic Tissue Constructs
Published on: December 13, 2019
Genetic predisposition in pancreatitis
1Division of Pediatric Gastroenterology, Hepatology and Nutrition, University of Toronto, and the Program of Translational Medicine, the Hospital for Sick Children, Toronto, Ontario, Canada.
Insights
Genetic mutations are key to childhood pancreatitis. Understanding individual genetic risks is vital for developing targeted therapies for acute recurrent pancreatitis and chronic pancreatitis.
Area of Science:
- Genetics and Molecular Biology
- Pediatric Gastroenterology
- Disease Pathogenesis
Background:
- Genetic mutations are the primary drivers of acute recurrent pancreatitis (ARP) and chronic pancreatitis in pediatric populations.
- Current medical approaches are shifting towards personalized strategies, necessitating a deeper understanding of individual disease risk factors.
Purpose of the Study:
- To review the current understanding of ARP and chronic pancreatitis as complex diseases.
- To highlight the role of genetic and non-genetic factors in disease development.
- To emphasize the need for individualized risk assessment and expert consultation.
Main Methods:
- Review of recent genetic cohort studies identifying novel pancreatitis-associated genes.
- Synthesis of findings on the interplay between genetic and non-genetic factors.
- Discussion of emerging trends in targeted pancreatitis therapy.
Main Results:
- Continuous discovery of new genes linked to pancreatitis through large-scale genetic studies.
- Evidence indicates that a combination of genetic and environmental factors contributes to individual pancreatitis risk.
- Promising developments are underway for future targeted therapeutic interventions.
Conclusions:
- ARP and chronic pancreatitis are complex multifactorial diseases.
- Thorough evaluation, including genetic profiling, is crucial for affected children.
- Consultation with pancreas experts can optimize patient management and consultation.
Purpose Of Review:
Genetic mutations are the primary cause for acute recurrent (ARP) and chronic pancreatitis in children. Further, our medical approach for many diseases is changing from a one-drug therapy to more individualized therapeutic strategies. In respect to the therapeutic management of ARP/chronic pancreatitis, this entails an understanding of the individual, mainly genetic, risk factors that led to pancreatitis disease.
Recent Findings:
New pancreatitis-associated genes are continuously emerging from increasingly large genetic cohort studies. Furthermore, newer research findings demonstrate that multiple genetic and nongenetic factors are required to increase the individual risk for developing ARP/chronic pancreatitis. Last, there is new exciting development towards targeted pancreatitis therapy in the future.
Summary:
This review introduces the current concept of ARP/chronic pancreatitis as a complex disease caused by multiple genetic and nongenetic factors. This warrants careful evaluation of these patients and ideally consultation of a pancreas expert to help understand individual genetic risk profiles and to provide more effective patient consultation.
Related Concept Videos
Genetics of Speciation
What is Population Genetics?
What is Genetic Engineering?
Animal Mitochondrial Genetics
Types of Genetic Transfer Between Organisms
Mutation, Gene Flow, and Genetic Drift

